Paul, Weiss, Rifkind, Wharton & Garrison represented Aptiv, while Ropes & Gray represented TPG Capital and its portfolio company Wind River in the transaction. Aptiv executed...
You must be a Standard 1 Year member to access this content.
Ropes & Gray has advised Intermediate Capital Group (ICG) on the deal. Travers Smith LLP has advised ECI Partners and senior management shareholders. Intermediate Capital Group...
You must be a Standard 1 Year member to access this content.
Kirkland & Ellis advised R1 RCM, Wachtell, Lipton, Rosen & Katz advised TowerBrook Capital Partners L.P., R1’s largest shareholder. Ropes & Gray acted as legal counsel...
You must be a Standard 1 Year member to access this content.
Ropes & Gray represented Global Healthcare Opportunities in the transaction. Global Healthcare Opportunities, or GHO Capital Partners LLP, executed its investment in Biocare Medical. Existing investor...
You must be a Standard 1 Year member to access this content.
Ropes & Gray represented McAfee, Fried, Frank, Harris, Shriver & Jacobson and Kirkland & Ellis advised Investor Group in the transaction. Weil, Gotshal & Manges advised...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised funds affiliated with Baring Private Equity Asia on the deal. Rahmat Lim & Partners acted for Baring. Baring Private Equity Asia (BPEA),...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised Takeda Pharmaceutical Company Limited in the deal. Takeda Pharmaceutical Company Limited announced an exclusive collaboration and license agreement with JCR Pharmaceuticals Co.,...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised Sunovion Pharmaceuticals on the deal while Cooley represented Otsuka Pharmaceutical. Sunovion Pharmaceuticals Inc., a subsidiary of Japan’s Sumitomo Dainippon Pharma, signed a...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised Avista Capital Partners, Nordic Capital and Acino on the deal. Acino announced its sale to ADQ, one of the Middle East’s largest holding...
You must be a Standard 1 Year member to access this content.
Ropes & Gray has advised Bridgepoint on the deal. Bridgepoint, the international private assets fund management group, completed its acquisition of Achilles, a global leader and...
You must be a Standard 1 Year member to access this content.
Ropes & Gray represented Adaptimmune in the deal. Adaptimmune signed its strategic collaboration with Roche Group’s Genentech Inc. to research, develop and commercialize cancer-target allogeneic T-cell...
You must be a Standard 1 Year member to access this content.
Cooley advised Intersect ENT on the deal, while Ropes & Gray advised Medtronic. Intersect ENT, a global ear, nose and throat medical technology leader dedicated to...
You must be a Standard 1 Year member to access this content.
